Join to View Full Profile
Danafarber Cancer Inst44 Binney StreetBoston, MA 02115
Phone+1 617-632-4903
Dr. Golub is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1989 - 1991
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1989
Certifications & Licensure
MA State Medical License 1994 - 2026
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2008
- Investigator Howard Hughes Medical Institute
Publications & Presentations
PubMed
- Genome-scale spatial mapping of the Hodgkin lymphoma microenvironment identifies tumor cell survival factors.Vignesh Shanmugam, Neriman Tokcan, Daniel Chafamo, Sean Sullivan, Mehdi Borji
Nature Communications. 2025-12-20 - Generative Design of Cell Type-Specific RNA Splicing Elements for Programmable Gene Regulation.Xi Dawn Chen, Maile Jim, Mounica Vallurupalli, Kai Cao, Andrea Navarro Torres
Biorxiv. 2025-11-05 - 22 citationsDiscovery of chromatin-based determinants of azacytidine and decitabine anti-cancer activity.Rishi V Puram, Qiangzong Yin, YuhJong Liu, Justine C Rutter, Daniel Bondeson
Biorxiv. 2025-08-01
Journal Articles
- Selective Gene Dependencies in MYCN-Amplified Neuroblastoma Include the Core Transcriptional Regulatory CircuitryWilliam C Hahn, Todd R Golub, A Thomas Look, Adam D Durbin, Neekesh V Dharia, Kimberly Stegmaier, Nature
- Genetic and Transcriptional Evolution Alters Cancer Cell Line Drug ResponseTodd R Golub, Rameen Beroukhim, Pratiti Bandopadhayay, Nature
- Retraction Note: Selective Killing of Cancer Cells by a Small Molecule Targeting the Stress Response to ROSStuart L Schreiber, Todd R Golub, Nature
Press Mentions
Dana-Farber Cancer Institute Faculty Among World's Most Highly Cited ResearchersNovember 19th, 2024- René Salazar Joins Broad Institute as Chief Equity OfficerOctober 14th, 2021
- 40th Anniversary Recollections & PredictionsOctober 4th, 2021
Grant Support
- Making cancer precision medicine real: bottlenecks and opportunitiesBROAD INSTITUTE, INC.2019–2026
- Broad Institute Center For Cancer Systems BiologyNational Cancer Institute2010–2012
- Large Scale Gene Expression Analysis Of Cellular StatesNational Human Genome Research Institute2010–2011
- Discovery Pipeline (2 Of 4)National Cancer Institute2009–2011
- Molecular Signatures Of Melanoma: Predicting Response To Therapy &TargetingNational Cancer Institute2008–2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
